title: TP receptor antagonists (TXRAs): expensive irrelevance or wonder drugs strangled at birth?
authors.forename: J M
authors.initials: JM
authors.lastname: Ritter
mesh_terms: D001241:Aspirin / Q000494:pharmacology*; D015195:Drug Design; D016032:Randomized Controlled Trials as Topic; D017482:Receptors, Thromboxane / Q000037:antagonists & inhibitors* / Q000627:therapeutic use
chemical_list: D017482:Receptors, Thromboxane; D001241:Aspirin